Is Social Media Now Defining Ocugen's (OCGN) Gene Therapy Investment Story More Than Its Science?

In recent days, Ocugen Inc has returned to the spotlight as a speculative biotech, with intense social media attention ...

Is It Too Late To Consider Teck Resources (TSX:TECK.B) After Recent Share Price Strength?

If you are wondering whether Teck Resources at about $68.99 is offering good value right now, you are not alone. Many ...

How Investors May Respond To Oddity Tech (ODD) CSO Exit Amid Methodiq AI Telehealth Expansion

In early January 2026, ODDITY Tech Ltd. reported that former ODDITY LABS Chief Science Officer Dr. Ido Bachelet had left the company, with his duties redistributed across the existing leadership team ...